Evaluation of the benefit/risk ratio of a reduction of tacrolimus dose in association with mycophenolate mofetil on the prevention of complications in adult liver transplantation.

Trial Profile

Evaluation of the benefit/risk ratio of a reduction of tacrolimus dose in association with mycophenolate mofetil on the prevention of complications in adult liver transplantation.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 03 Jul 2012

At a glance

  • Drugs Mycophenolate mofetil (Primary) ; Tacrolimus (Primary)
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Mar 2012 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
    • 23 Jan 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 03 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top